Johnson Matthey (LON:JMAT) PT Raised to GBX 1,800 at Berenberg Bank

Johnson Matthey (LON:JMATFree Report) had its price objective hoisted by Berenberg Bank from GBX 1,650 ($20.88) to GBX 1,800 ($22.78) in a research note released on Monday morning, Marketbeat Ratings reports. Berenberg Bank currently has a hold rating on the stock.

A number of other equities research analysts have also recently commented on the stock. Jefferies Financial Group restated a buy rating and issued a GBX 2,100 ($26.58) price target on shares of Johnson Matthey in a report on Wednesday, March 20th. Numis Securities reiterated a buy rating and set a GBX 2,200 ($27.84) price objective on shares of Johnson Matthey in a report on Wednesday, March 20th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Johnson Matthey currently has an average rating of Moderate Buy and an average target price of GBX 2,010 ($25.44).

Get Our Latest Analysis on JMAT

Johnson Matthey Trading Up 0.3 %

LON:JMAT opened at GBX 1,784 ($22.58) on Monday. The company has a current ratio of 1.51, a quick ratio of 0.76 and a debt-to-equity ratio of 63.95. The stock has a market capitalization of £3.27 billion, a price-to-earnings ratio of 1,839.18, a PEG ratio of 49,242.50 and a beta of 0.96. The firm has a fifty day simple moving average of GBX 1,684.23 and a two-hundred day simple moving average of GBX 1,620.49. Johnson Matthey has a 12 month low of GBX 1,428.50 ($18.08) and a 12 month high of GBX 1,999 ($25.30).

Insider Activity at Johnson Matthey

In other news, insider Stephen Oxley purchased 18 shares of the company’s stock in a transaction that occurred on Wednesday, March 20th. The shares were bought at an average cost of GBX 1,864 ($23.59) per share, with a total value of £335.52 ($424.66). Insiders have bought 66 shares of company stock valued at $109,920 over the last ninety days. Corporate insiders own 0.57% of the company’s stock.

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Stories

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.